FDA Inspection 1113305 — Oklahoma Blood Institute Southern
The FDA completed an inspection of Oklahoma Blood Institute Southern on Dec 13, 2019 in Ardmore, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 13, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ardmore, OK (United States)